>
Belluscura logo

BELL - Belluscura Share Price

68.5p 0.0  0.0%

Last Trade - 04/08/21

Sector
Healthcare
Size
Small Cap
Market Cap £77.6m
Enterprise Value £77.6m
Revenue £n/a
Position in Universe th / 1799
Bullish
Bearish
Unlock BELL Revenue
Momentum
Relative Strength (%)
1m +22.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.16%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.13 0.000 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Belluscura PLC revenues decreased from $129K to $0K. Netloss increased 27% to $2M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Higher net loss reflectsAdministrative expenses increase of 24% to $2M (expense),Other operating income decrease of 74% to $11K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BELL Revenue Unlock BELL Revenue

Net Income

BELL Net Income Unlock BELL Revenue

Normalised EPS

BELL Normalised EPS Unlock BELL Revenue

PE Ratio Range

BELL PE Ratio Range Unlock BELL Revenue

Dividend Yield Range

BELL Dividend Yield Range Unlock BELL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BELL EPS Forecasts Unlock BELL Revenue
Profile Summary

Belluscura PLC is a United Kingdom-based medical devices company. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. It focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The Company is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.

Directors
Last Annual December 31st, 2020
Last Interim January 1st, 1970
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange London Stock Exchange (AIM)
Shares in Issue 113,307,401
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BELL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BELL
Upcoming Events for BELL
Frequently Asked Questions for Belluscura
What is the Belluscura share price?

As of 04/08/21, shares in Belluscura are trading at 68.5p, giving the company a market capitalisation of £77.6m. This share price information is delayed by 15 minutes.

How has the Belluscura share price performed this year?

Shares in Belluscura are currently trading at 68.5p and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Belluscura price has moved by % over the past year.

What are the analyst and broker recommendations for Belluscura?

There are no analysts currently covering Belluscura.

When will Belluscura next release its financial results?

It is not known when Belluscura will next release financial results.

What is the Belluscura dividend yield?

Belluscura does not currently pay a dividend.

Does Belluscura pay a dividend?

Belluscura does not currently pay a dividend.

When does Belluscura next pay dividends?

Belluscura does not currently pay a dividend.

How do I buy Belluscura shares?

To buy shares in Belluscura you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Belluscura?

Shares in Belluscura are currently trading at 68.5p, giving the company a market capitalisation of £77.6m.

Where are Belluscura shares listed? Where are Belluscura shares listed?

Here are the trading details for Belluscura:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: BELL
What kind of share is Belluscura?

We were not able to load our ranking data for Belluscura

Is there a Belluscura share price forecast 2021?

We were not able to load any forecast data for Belluscura.

How can I tell whether the Belluscura share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Belluscura. Over the past six months, the relative strength of its shares against the market has been %. At the current price of 68.5p, shares in Belluscura are trading at 15.78% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Belluscura PE Ratio?

We were not able to find PE ratio data for Belluscura.

Who are the key directors of Belluscura?

We were unable to find the directors for Belluscura.

Who are the major shareholders of Belluscura?

Here are the top five shareholders of Belluscura based on the size of their shareholding:

Tekcapital PLC Corporation
Percentage owned: 15.13% (17.1m shares)
Wray (Nigel) Individual Investor
Percentage owned: 11.97% (13.6m shares)
Poutney (David John) Individual Investor
Percentage owned: 10.24% (11.6m shares)
Dowgate Capital Limited Independent Research Firm
Percentage owned: 4.57% (5.18m shares)
RBC Trust Co (International) Ltd Investment Advisor
Percentage owned: 3.72% (4.22m shares)
Similar to BELL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.